T. Rowe Price Associates’s Legence Corp LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.93M Buy
69,605
+42,865
+160% +$3.49M ﹤0.01% 1487
2026
Q1
$1.51M Buy
26,740
+5,414
+25% +$273K ﹤0.01% 1957
2025
Q4
$918K Buy
+21,326
New +$843K ﹤0.01% 2120

Other funds holding LGN

T. Rowe Price Associates's LGN Position: Q2 2026 in Review

T. Rowe Price Associates increased its Legence Corp (LGN) stake by 160% in Q2 2026, buying an estimated $3.49M and bringing the position to 69,605 shares worth $5.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

T. Rowe Price Associates first reported a position in LGN in Q4 2025 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold LGN as of Q2 2026.

  • T. Rowe Price Associates held 69,605 shares of Legence Corp worth $5.93M as of Q2 2026.
  • T. Rowe Price Associates bought 42,865 Legence Corp shares in Q2 2026, an estimated $3.49M.
  • Legence Corp made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1487 holding.
  • T. Rowe Price Associates first reported a position in Legence Corp in Q4 2025 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Legence Corp as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.